Evidence map›Paper›PMID 42564179›Full record

ArticleFrontiers in chemistry2026

Enhanced adsorption of ciprofloxacin from water using raw and phosphoric acid-modified cauliflower-leaves derived biochar: response surface optimization.

Qazi Saliq, Muhammad Rizwan, Sheeraz Ahmed Memon, Alin Ciobica, Vasile Burlui, Daniela Tomita, Hajira Haroon

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qazi SaliqDepartment of Environmental Sciences, University of Haripur, Haripur, Khyber Pakhtunkhwa, Pakistan.
Muhammad RizwanU.S.-Pakistan Center for Advanced Studies in Water, Mehran University of Engineering and Technology, Jamshoro, Pakistan.
Sheeraz Ahmed MemonDepartment of Environmental Engineering and Management, Mehran University of Engineering and Technology, Jamshoro, Pakistan.
Alin CiobicaDepartment of Biology, Faculty of Biology, Alexandru Ioan Cuza University of Iasi, Iasi, Romania.
Vasile Burlui"Ioan Haulica" Institute, Apollonia University, Iasi, Romania.
Daniela Tomita"Ioan Haulica" Institute, Apollonia University, Iasi, Romania.
Hajira HaroonDepartment of Environmental Sciences, University of Haripur, Haripur, Khyber Pakhtunkhwa, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ciprofloxacin (CIP), a widely prescribed fluoroquinolone antibiotic, has emerged as an environmental concern because of its persistence in aquatic systems, limited removal by conventional treatment processes, and role in the spread of antibiotic resistance. While biochar adsorption has gained attention for pharmaceutical removal, the use of cauliflower-leaf-derived biochar, particularly after chemical modification, has received limited investigation. Furthermore, studies integrating optimization of both biochar preparation and adsorption performance remain scarce. In the present study, raw cauliflower-leaf biochar (CLB10) and phosphoric-acid-modified biochar (PAM-CLB1.5) were evaluated for CIP removal from water using Response Surface Methodology based on a Box-Behnken experimental design. The optimized preparation conditions, i.e., pyrolysis time, temperature, and particle size for CLB10 were identified as 90 min, 475 °C, and 272.5 μm, respectively. Under optimized adsorption conditions, CLB10 achieved 78.43% CIP removal, whereas PAM-CLB1.5 exhibited substantially higher removal efficiency (97.54%), demonstrating the beneficial effect of phosphoric acid modification. Surface characterization showed that acid treatment enhanced pore development, increased specific surface area from 15.03 to 24.65 m

Indexed as

adsorptionbiocharciprofloxacinisothermskineticsresponse surface methodology

Identifiers

PMID42564179
PMCPMC13442430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.